Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial

Anan Manomaipiboon; Kitisak Pholtawornkulchai; Sujaree Pupipatpab; Swangjit Suraamornkul; Jakravoot Maneerit; Wiroj Ruksakul; Uraporn Phumisantiphong; Thananda Trakarnvanich

Research Square Platform LLC (2022) - Comments
doi: 10.21203/rs.3.rs-1290999/v1

Anan Manomaipiboon, Kitisak Pholtawornkulchai, Sujaree Pupipatpab, Swangjit Suraamornkul, Jakravoot Maneerit, Wiroj Ruksakul, Uraporn Phumisantiphong, Thananda Trakarnvanich